Found 69 hits with Last Name = 'engelhardt' and Initial = 'e' Target/Host
(Institution) | Ligand | Target/Host
Links | Ligand
Links | Trg + Lig
Links | Ki
nM | ΔG°
kJ/mole | IC50
nM | Kd
nM | EC50/IC50
nM | koff
s-1 | kon
M-1s-1 | pH | Temp
°C |
|---|
Delta-type opioid receptor/Kappa-type opioid receptor/Mu-type opioid receptor/Sigma non-opioid intracellular receptor 1
(Rattus norvegicus (rat)-RAT) | BDBM50223497
(CHEMBL26232)Show SMILES Cl.[#6]-[#6]-[#6]1-[#6]-2-[#6]-c3ccc(-[#8])cc3C1([#6]-[#6])[#6]-[#6]-[#7]-2-[#6](=O)-[#6](-[#7])-[#6]-[#6]-[#6]\[#7]=[#6](/[#7])-[#7] |TLB:11:12:3:18.17.16| Show InChI InChI=1S/C22H35N5O2.ClH/c1-3-16-19-12-14-7-8-15(28)13-17(14)22(16,4-2)9-11-27(19)20(29)18(23)6-5-10-26-21(24)25;/h7-8,13,16,18-19,28H,3-6,9-12,23H2,1-2H3,(H4,24,25,26);1H | PDB
MMDB
Reactome pathway
KEGG
UniProtKB/SwissProt
B.MOAD
DrugBank
GoogleScholar
AffyNet 
| CHEMBL
PC cid
PC sid
UniChem
Similars
| PubMed
| n/a | n/a | 16 | n/a | n/a | n/a | n/a | n/a | n/a |
TBA
Curated by ChEMBL
| Assay Description
Compound was tested for its ability to displace [3H]naloxone from Opioid receptors in absence of NaCl |
J Med Chem 24: 1297-9 (1981)
BindingDB Entry DOI: 10.7270/Q20C4XZN |
More data for this
Ligand-Target Pair | |
Delta-type opioid receptor/Kappa-type opioid receptor/Mu-type opioid receptor/Sigma non-opioid intracellular receptor 1
(Rattus norvegicus (rat)-RAT) | BDBM50019056
((S)-2-[(S)-2-(2-{2-[(S)-2-Amino-3-(4-hydroxy-pheny...)Show SMILES CSCC[C@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)CNC(=O)CNC(=O)[C@@H](N)Cc1ccc(O)cc1)C(O)=O Show InChI InChI=1S/C27H35N5O7S/c1-40-12-11-21(27(38)39)32-26(37)22(14-17-5-3-2-4-6-17)31-24(35)16-29-23(34)15-30-25(36)20(28)13-18-7-9-19(33)10-8-18/h2-10,20-22,33H,11-16,28H2,1H3,(H,29,34)(H,30,36)(H,31,35)(H,32,37)(H,38,39)/t20-,21-,22-/m0/s1 | PDB
MMDB
Reactome pathway
KEGG
UniProtKB/SwissProt
B.MOAD
DrugBank
GoogleScholar
AffyNet
| Purchase
CHEMBL
MCE
KEGG
PC cid
PC sid
UniChem
Similars
| PubMed
| n/a | n/a | 18 | n/a | n/a | n/a | n/a | n/a | n/a |
TBA
Curated by ChEMBL
| Assay Description
Compound was tested for its ability to displace [3H]naloxone from Opioid receptors in absence of NaCl |
J Med Chem 24: 1297-9 (1981)
BindingDB Entry DOI: 10.7270/Q20C4XZN |
More data for this
Ligand-Target Pair | |
Delta-type opioid receptor/Kappa-type opioid receptor/Mu-type opioid receptor/Sigma non-opioid intracellular receptor 1
(Rattus norvegicus (rat)-RAT) | BDBM50223493
(CHEMBL24175)Show SMILES [H][C@]12Cc3ccc(O)cc3[C@](CC)(CCN1)[C@@]2([H])CC |THB:18:16:9.3.2:15.13.14| Show InChI InChI=1S/C16H23NO/c1-3-13-15-9-11-5-6-12(18)10-14(11)16(13,4-2)7-8-17-15/h5-6,10,13,15,17-18H,3-4,7-9H2,1-2H3/t13-,15+,16+/m0/s1 | PDB
MMDB
Reactome pathway
KEGG
UniProtKB/SwissProt
B.MOAD
DrugBank
GoogleScholar
AffyNet
| CHEMBL
PC cid
PC sid
UniChem
Similars
| PubMed
| n/a | n/a | 20 | n/a | n/a | n/a | n/a | n/a | n/a |
TBA
Curated by ChEMBL
| Assay Description
Compound was tested for its ability to displace [3H]- naloxone] from Opioid receptors in absence of NaCl |
J Med Chem 24: 1297-9 (1981)
BindingDB Entry DOI: 10.7270/Q20C4XZN |
More data for this
Ligand-Target Pair | |
Plasminogen activator inhibitor 1
(Homo sapiens (Human)) | BDBM50111316
(8-[4-(3,6-Dioxo-5-{4-[(thiophene-2-carbonyl)-amino...)Show SMILES OC(=O)CCCCCCCOc1ccc(\C=c2\[nH]c(=O)\c(=C\c3ccc(NC(=O)c4cccs4)cc3)[nH]c2=O)cc1 Show InChI InChI=1S/C31H31N3O6S/c35-28(36)8-4-2-1-3-5-17-40-24-15-11-22(12-16-24)20-26-30(38)33-25(29(37)34-26)19-21-9-13-23(14-10-21)32-31(39)27-7-6-18-41-27/h6-7,9-16,18-20H,1-5,8,17H2,(H,32,39)(H,33,38)(H,34,37)(H,35,36)/b25-19-,26-20+ | PDB
MMDB
Reactome pathway
KEGG
UniProtKB/SwissProt
B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet
| CHEMBL
PC cid
PC sid
UniChem
Similars
| PubMed
| n/a | n/a | 200 | n/a | n/a | n/a | n/a | n/a | n/a |
Xenova Limited
Curated by ChEMBL
| Assay Description
Inhibitory activity against human plasminogen activator inhibitor-1(PAI-1) evaluated by chromogenic assay. |
Bioorg Med Chem Lett 12: 1063-6 (2002)
BindingDB Entry DOI: 10.7270/Q2W958HQ |
More data for this
Ligand-Target Pair | |
Delta-type opioid receptor/Kappa-type opioid receptor/Mu-type opioid receptor/Sigma non-opioid intracellular receptor 1
(Rattus norvegicus (rat)-RAT) | BDBM50019056
((S)-2-[(S)-2-(2-{2-[(S)-2-Amino-3-(4-hydroxy-pheny...)Show SMILES CSCC[C@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)CNC(=O)CNC(=O)[C@@H](N)Cc1ccc(O)cc1)C(O)=O Show InChI InChI=1S/C27H35N5O7S/c1-40-12-11-21(27(38)39)32-26(37)22(14-17-5-3-2-4-6-17)31-24(35)16-29-23(34)15-30-25(36)20(28)13-18-7-9-19(33)10-8-18/h2-10,20-22,33H,11-16,28H2,1H3,(H,29,34)(H,30,36)(H,31,35)(H,32,37)(H,38,39)/t20-,21-,22-/m0/s1 | PDB
MMDB
Reactome pathway
KEGG
UniProtKB/SwissProt
B.MOAD
DrugBank
GoogleScholar
AffyNet
| Purchase
CHEMBL
MCE
KEGG
PC cid
PC sid
UniChem
Similars
| PubMed
| n/a | n/a | 240 | n/a | n/a | n/a | n/a | n/a | n/a |
TBA
Curated by ChEMBL
| Assay Description
Compound was tested for its ability to displace [3H]naloxone from Opioid receptors in presence of NaCl (100 mM) |
J Med Chem 24: 1297-9 (1981)
BindingDB Entry DOI: 10.7270/Q20C4XZN |
More data for this
Ligand-Target Pair | |
Delta-type opioid receptor/Kappa-type opioid receptor/Mu-type opioid receptor/Sigma non-opioid intracellular receptor 1
(Rattus norvegicus (rat)-RAT) | BDBM50223498
(CHEMBL286206)Show SMILES Cl.CCC1C2Cc3ccc(O)cc3C1(CC)CCN2C(=O)CN |TLB:11:12:3:18.17.16| Show InChI InChI=1S/C18H26N2O2.ClH/c1-3-14-16-9-12-5-6-13(21)10-15(12)18(14,4-2)7-8-20(16)17(22)11-19;/h5-6,10,14,16,21H,3-4,7-9,11,19H2,1-2H3;1H | PDB
MMDB
Reactome pathway
KEGG
UniProtKB/SwissProt
B.MOAD
DrugBank
GoogleScholar
AffyNet
| CHEMBL
PC cid
PC sid
UniChem
Similars
| PubMed
| n/a | n/a | 287 | n/a | n/a | n/a | n/a | n/a | n/a |
TBA
Curated by ChEMBL
| Assay Description
Compound was tested for its ability to displace [3H]naloxone from Opioid receptors in absence of NaCl |
J Med Chem 24: 1297-9 (1981)
BindingDB Entry DOI: 10.7270/Q20C4XZN |
More data for this
Ligand-Target Pair | |
Plasminogen activator inhibitor 1
(Homo sapiens (Human)) | BDBM50111273
(6-Benzo[b]thiophen-2-yl-4-hydroxy-2-oxo-1,2-dihydr...)Show SMILES Oc1c(C(=O)Nc2ccc(OCCCCCCCn3cnnn3)cc2)c(=O)[nH]c2ccc(cc12)-c1cc2ccccc2s1 Show InChI InChI=1S/C32H30N6O4S/c39-30-25-18-22(28-19-21-8-4-5-9-27(21)43-28)10-15-26(25)35-32(41)29(30)31(40)34-23-11-13-24(14-12-23)42-17-7-3-1-2-6-16-38-20-33-36-37-38/h4-5,8-15,18-20H,1-3,6-7,16-17H2,(H,34,40)(H2,35,39,41) | PDB
MMDB
Reactome pathway
KEGG
UniProtKB/SwissProt
B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet
| CHEMBL
PC cid
PC sid
UniChem
Similars
| PubMed
| n/a | n/a | 290 | n/a | n/a | n/a | n/a | n/a | n/a |
Xenova Limited
Curated by ChEMBL
| Assay Description
Inhibitory activity against human plasminogen activator inhibitor-1(PAI-1) evaluated by complex assay. |
Bioorg Med Chem Lett 12: 1063-6 (2002)
BindingDB Entry DOI: 10.7270/Q2W958HQ |
More data for this
Ligand-Target Pair | |
Plasminogen activator inhibitor 1
(Homo sapiens (Human)) | BDBM50111280
(1-(4-Chloro-phenyl)-4-hydroxy-2-oxo-2,5-dihydro-1H...)Show SMILES Clc1ccc(cc1)N1CC(=O)C(C(=O)Nc2ccc(OCCCCCCCn3cnnn3)cc2)C1=O Show InChI InChI=1S/C25H27ClN6O4/c26-18-6-10-20(11-7-18)32-16-22(33)23(25(32)35)24(34)28-19-8-12-21(13-9-19)36-15-5-3-1-2-4-14-31-17-27-29-30-31/h6-13,17,23H,1-5,14-16H2,(H,28,34) | PDB
MMDB
Reactome pathway
KEGG
UniProtKB/SwissProt
B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet
| CHEMBL
PC cid
PC sid
UniChem
Similars
| PubMed
| n/a | n/a | 300 | n/a | n/a | n/a | n/a | n/a | n/a |
Xenova Limited
Curated by ChEMBL
| Assay Description
Inhibitory activity against human plasminogen activator inhibitor-1(PAI-1) evaluated by complex assay. |
Bioorg Med Chem Lett 12: 1063-6 (2002)
BindingDB Entry DOI: 10.7270/Q2W958HQ |
More data for this
Ligand-Target Pair | |
Plasminogen activator inhibitor 1
(Homo sapiens (Human)) | BDBM50111298
(8-{4-[(7-Benzo[b]thiophen-2-yl-4-hydroxy-2-oxo-1,2...)Show SMILES OC(=O)CCCCCCCOc1ccc(NC(=O)c2c(O)c3ccc(cc3[nH]c2=O)-c2cc3ccccc3s2)cc1 Show InChI InChI=1S/C32H30N2O6S/c35-28(36)10-4-2-1-3-7-17-40-23-14-12-22(13-15-23)33-31(38)29-30(37)24-16-11-21(18-25(24)34-32(29)39)27-19-20-8-5-6-9-26(20)41-27/h5-6,8-9,11-16,18-19H,1-4,7,10,17H2,(H,33,38)(H,35,36)(H2,34,37,39) | PDB
MMDB
Reactome pathway
KEGG
UniProtKB/SwissProt
B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet
| CHEMBL
PC cid
PC sid
UniChem
Similars
| PubMed
| n/a | n/a | 300 | n/a | n/a | n/a | n/a | n/a | n/a |
Xenova Limited
Curated by ChEMBL
| Assay Description
Inhibitory activity against human plasminogen activator inhibitor-1(PAI-1) evaluated by chromogenic assay. |
Bioorg Med Chem Lett 12: 1063-6 (2002)
BindingDB Entry DOI: 10.7270/Q2W958HQ |
More data for this
Ligand-Target Pair | |
Delta-type opioid receptor/Kappa-type opioid receptor/Mu-type opioid receptor/Sigma non-opioid intracellular receptor 1
(Rattus norvegicus (rat)-RAT) | BDBM50223496
(CHEMBL282347)Show SMILES Cl.CCC1C2Cc3ccc(O)cc3C1(CC)CCN2C(=O)C(N)CCSC |TLB:11:12:3:18.17.16| Show InChI InChI=1S/C21H32N2O2S.ClH/c1-4-16-19-12-14-6-7-15(24)13-17(14)21(16,5-2)9-10-23(19)20(25)18(22)8-11-26-3;/h6-7,13,16,18-19,24H,4-5,8-12,22H2,1-3H3;1H | PDB
MMDB
Reactome pathway
KEGG
UniProtKB/SwissProt
B.MOAD
DrugBank
GoogleScholar
AffyNet
| CHEMBL
PC cid
PC sid
UniChem
Similars
| PubMed
| n/a | n/a | 301 | n/a | n/a | n/a | n/a | n/a | n/a |
TBA
Curated by ChEMBL
| Assay Description
Compound was tested for its ability to displace [3H]naloxone from Opioid receptors in absence of NaCl |
J Med Chem 24: 1297-9 (1981)
BindingDB Entry DOI: 10.7270/Q20C4XZN |
More data for this
Ligand-Target Pair | |
Delta-type opioid receptor/Kappa-type opioid receptor/Mu-type opioid receptor/Sigma non-opioid intracellular receptor 1
(Rattus norvegicus (rat)-RAT) | BDBM50223493
(CHEMBL24175)Show SMILES [H][C@]12Cc3ccc(O)cc3[C@](CC)(CCN1)[C@@]2([H])CC |THB:18:16:9.3.2:15.13.14| Show InChI InChI=1S/C16H23NO/c1-3-13-15-9-11-5-6-12(18)10-14(11)16(13,4-2)7-8-17-15/h5-6,10,13,15,17-18H,3-4,7-9H2,1-2H3/t13-,15+,16+/m0/s1 | PDB
MMDB
Reactome pathway
KEGG
UniProtKB/SwissProt
B.MOAD
DrugBank
GoogleScholar
AffyNet
| CHEMBL
PC cid
PC sid
UniChem
Similars
| PubMed
| n/a | n/a | 360 | n/a | n/a | n/a | n/a | n/a | n/a |
TBA
Curated by ChEMBL
| Assay Description
Compound was tested for its ability to displace [3H]- naloxone] from Opioid receptors in presence of NaCl (100 mM) |
J Med Chem 24: 1297-9 (1981)
BindingDB Entry DOI: 10.7270/Q20C4XZN |
More data for this
Ligand-Target Pair | |
Plasminogen activator inhibitor 1
(Homo sapiens (Human)) | BDBM50111292
(8-{4-[(6-Benzo[b]thiophen-2-yl-4-hydroxy-2-oxo-1,2...)Show SMILES OC(=O)CCCCCCCOc1ccc(NC(=O)c2c(O)c3cc(ccc3[nH]c2=O)-c2cc3ccccc3s2)cc1 Show InChI InChI=1S/C32H30N2O6S/c35-28(36)10-4-2-1-3-7-17-40-23-14-12-22(13-15-23)33-31(38)29-30(37)24-18-21(11-16-25(24)34-32(29)39)27-19-20-8-5-6-9-26(20)41-27/h5-6,8-9,11-16,18-19H,1-4,7,10,17H2,(H,33,38)(H,35,36)(H2,34,37,39) | PDB
MMDB
Reactome pathway
KEGG
UniProtKB/SwissProt
B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet
| CHEMBL
PC cid
PC sid
UniChem
Similars
| PubMed
| n/a | n/a | 500 | n/a | n/a | n/a | n/a | n/a | n/a |
Xenova Limited
Curated by ChEMBL
| Assay Description
Inhibitory activity against human plasminogen activator inhibitor-1(PAI-1) evaluated by chromogenic assay. |
Bioorg Med Chem Lett 12: 1063-6 (2002)
BindingDB Entry DOI: 10.7270/Q2W958HQ |
More data for this
Ligand-Target Pair | |
Plasminogen activator inhibitor 1
(Homo sapiens (Human)) | BDBM50111316
(8-[4-(3,6-Dioxo-5-{4-[(thiophene-2-carbonyl)-amino...)Show SMILES OC(=O)CCCCCCCOc1ccc(\C=c2\[nH]c(=O)\c(=C\c3ccc(NC(=O)c4cccs4)cc3)[nH]c2=O)cc1 Show InChI InChI=1S/C31H31N3O6S/c35-28(36)8-4-2-1-3-5-17-40-24-15-11-22(12-16-24)20-26-30(38)33-25(29(37)34-26)19-21-9-13-23(14-10-21)32-31(39)27-7-6-18-41-27/h6-7,9-16,18-20H,1-5,8,17H2,(H,32,39)(H,33,38)(H,34,37)(H,35,36)/b25-19-,26-20+ | PDB
MMDB
Reactome pathway
KEGG
UniProtKB/SwissProt
B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet
| CHEMBL
PC cid
PC sid
UniChem
Similars
| PubMed
| n/a | n/a | 510 | n/a | n/a | n/a | n/a | n/a | n/a |
Xenova Limited
Curated by ChEMBL
| Assay Description
Inhibitory activity against human plasminogen activator inhibitor-1(PAI-1) evaluated by complex assay. |
Bioorg Med Chem Lett 12: 1063-6 (2002)
BindingDB Entry DOI: 10.7270/Q2W958HQ |
More data for this
Ligand-Target Pair | |
Plasminogen activator inhibitor 1
(Homo sapiens (Human)) | BDBM50111309
(8-{4-[(6-Benzo[b]thiophen-3-yl-4-hydroxy-2-oxo-1,2...)Show SMILES OC(=O)CCCCCCCOc1ccc(NC(=O)c2c(O)c3cc(ccc3[nH]c2=O)-c2csc3ccccc23)cc1 Show InChI InChI=1S/C32H30N2O6S/c35-28(36)10-4-2-1-3-7-17-40-22-14-12-21(13-15-22)33-31(38)29-30(37)24-18-20(11-16-26(24)34-32(29)39)25-19-41-27-9-6-5-8-23(25)27/h5-6,8-9,11-16,18-19H,1-4,7,10,17H2,(H,33,38)(H,35,36)(H2,34,37,39) | PDB
MMDB
Reactome pathway
KEGG
UniProtKB/SwissProt
B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet
| CHEMBL
PC cid
PC sid
UniChem
Similars
| PubMed
| n/a | n/a | 510 | n/a | n/a | n/a | n/a | n/a | n/a |
Xenova Limited
Curated by ChEMBL
| Assay Description
Inhibitory activity against human plasminogen activator inhibitor-1(PAI-1) evaluated by chromogenic assay. |
Bioorg Med Chem Lett 12: 1063-6 (2002)
BindingDB Entry DOI: 10.7270/Q2W958HQ |
More data for this
Ligand-Target Pair | |
Plasminogen activator inhibitor 1
(Homo sapiens (Human)) | BDBM50111281
(8-{4-[(4-Hydroxy-7-naphthalen-2-yl-2-oxo-1,2-dihyd...)Show SMILES OC(=O)CCCCCCCOc1ccc(NC(=O)c2c(O)c3ccc(cc3[nH]c2=O)-c2ccc3ccccc3c2)cc1 Show InChI InChI=1S/C34H32N2O6/c37-30(38)10-4-2-1-3-7-19-42-27-16-14-26(15-17-27)35-33(40)31-32(39)28-18-13-25(21-29(28)36-34(31)41)24-12-11-22-8-5-6-9-23(22)20-24/h5-6,8-9,11-18,20-21H,1-4,7,10,19H2,(H,35,40)(H,37,38)(H2,36,39,41) | PDB
MMDB
Reactome pathway
KEGG
UniProtKB/SwissProt
B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet
| CHEMBL
PC cid
PC sid
UniChem
Similars
| PubMed
| n/a | n/a | 600 | n/a | n/a | n/a | n/a | n/a | n/a |
Xenova Limited
Curated by ChEMBL
| Assay Description
Inhibitory activity against human plasminogen activator inhibitor-1(PAI-1) evaluated by chromogenic assay. |
Bioorg Med Chem Lett 12: 1063-6 (2002)
BindingDB Entry DOI: 10.7270/Q2W958HQ |
More data for this
Ligand-Target Pair | |
Delta-type opioid receptor/Kappa-type opioid receptor/Mu-type opioid receptor/Sigma non-opioid intracellular receptor 1
(Rattus norvegicus (rat)-RAT) | BDBM50223497
(CHEMBL26232)Show SMILES Cl.[#6]-[#6]-[#6]1-[#6]-2-[#6]-c3ccc(-[#8])cc3C1([#6]-[#6])[#6]-[#6]-[#7]-2-[#6](=O)-[#6](-[#7])-[#6]-[#6]-[#6]\[#7]=[#6](/[#7])-[#7] |TLB:11:12:3:18.17.16| Show InChI InChI=1S/C22H35N5O2.ClH/c1-3-16-19-12-14-7-8-15(28)13-17(14)22(16,4-2)9-11-27(19)20(29)18(23)6-5-10-26-21(24)25;/h7-8,13,16,18-19,28H,3-6,9-12,23H2,1-2H3,(H4,24,25,26);1H | PDB
MMDB
Reactome pathway
KEGG
UniProtKB/SwissProt
B.MOAD
DrugBank
GoogleScholar
AffyNet
| CHEMBL
PC cid
PC sid
UniChem
Similars
| PubMed
| n/a | n/a | 660 | n/a | n/a | n/a | n/a | n/a | n/a |
TBA
Curated by ChEMBL
| Assay Description
Compound was tested for its ability to displace [3H]naloxone from Opioid receptors in presence of NaCl (100 mM) |
J Med Chem 24: 1297-9 (1981)
BindingDB Entry DOI: 10.7270/Q20C4XZN |
More data for this
Ligand-Target Pair | |
Plasminogen activator inhibitor 1
(Homo sapiens (Human)) | BDBM50111282
(8-{4-[(4-Hydroxy-6-naphthalen-2-yl-2-oxo-1,2-dihyd...)Show SMILES OC(=O)CCCCCCCOc1ccc(NC(=O)c2c(O)c3cc(ccc3[nH]c2=O)-c2ccc3ccccc3c2)cc1 Show InChI InChI=1S/C34H32N2O6/c37-30(38)10-4-2-1-3-7-19-42-27-16-14-26(15-17-27)35-33(40)31-32(39)28-21-25(13-18-29(28)36-34(31)41)24-12-11-22-8-5-6-9-23(22)20-24/h5-6,8-9,11-18,20-21H,1-4,7,10,19H2,(H,35,40)(H,37,38)(H2,36,39,41) | PDB
MMDB
Reactome pathway
KEGG
UniProtKB/SwissProt
B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet
| CHEMBL
PC cid
PC sid
UniChem
Similars
| PubMed
| n/a | n/a | 670 | n/a | n/a | n/a | n/a | n/a | n/a |
Xenova Limited
Curated by ChEMBL
| Assay Description
Inhibitory activity against human plasminogen activator inhibitor-1(PAI-1) evaluated by chromogenic assay. |
Bioorg Med Chem Lett 12: 1063-6 (2002)
BindingDB Entry DOI: 10.7270/Q2W958HQ |
More data for this
Ligand-Target Pair | |
Plasminogen activator inhibitor 1
(Homo sapiens (Human)) | BDBM50111280
(1-(4-Chloro-phenyl)-4-hydroxy-2-oxo-2,5-dihydro-1H...)Show SMILES Clc1ccc(cc1)N1CC(=O)C(C(=O)Nc2ccc(OCCCCCCCn3cnnn3)cc2)C1=O Show InChI InChI=1S/C25H27ClN6O4/c26-18-6-10-20(11-7-18)32-16-22(33)23(25(32)35)24(34)28-19-8-12-21(13-9-19)36-15-5-3-1-2-4-14-31-17-27-29-30-31/h6-13,17,23H,1-5,14-16H2,(H,28,34) | PDB
MMDB
Reactome pathway
KEGG
UniProtKB/SwissProt
B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet
| CHEMBL
PC cid
PC sid
UniChem
Similars
| PubMed
| n/a | n/a | 690 | n/a | n/a | n/a | n/a | n/a | n/a |
Xenova Limited
Curated by ChEMBL
| Assay Description
Inhibitory activity against human plasminogen activator inhibitor-1(PAI-1) evaluated by chromogenic assay. |
Bioorg Med Chem Lett 12: 1063-6 (2002)
BindingDB Entry DOI: 10.7270/Q2W958HQ |
More data for this
Ligand-Target Pair | |
Plasminogen activator inhibitor 1
(Homo sapiens (Human)) | BDBM50111279
(4-Hydroxy-2-oxo-1-p-tolyl-2,5-dihydro-1H-pyrrole-3...)Show SMILES Cc1ccc(cc1)N1CC(=O)C(C(=O)Nc2ccc(OCCCCCCCn3cnnn3)cc2)C1=O Show InChI InChI=1S/C26H30N6O4/c1-19-7-11-21(12-8-19)32-17-23(33)24(26(32)35)25(34)28-20-9-13-22(14-10-20)36-16-6-4-2-3-5-15-31-18-27-29-30-31/h7-14,18,24H,2-6,15-17H2,1H3,(H,28,34) | PDB
MMDB
Reactome pathway
KEGG
UniProtKB/SwissProt
B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet
| CHEMBL
PC cid
PC sid
UniChem
Similars
| PubMed
| n/a | n/a | 830 | n/a | n/a | n/a | n/a | n/a | n/a |
Xenova Limited
Curated by ChEMBL
| Assay Description
Inhibitory activity against human plasminogen activator inhibitor-1(PAI-1) evaluated by chromogenic assay. |
Bioorg Med Chem Lett 12: 1063-6 (2002)
BindingDB Entry DOI: 10.7270/Q2W958HQ |
More data for this
Ligand-Target Pair | |
Plasminogen activator inhibitor 1
(Homo sapiens (Human)) | BDBM50111279
(4-Hydroxy-2-oxo-1-p-tolyl-2,5-dihydro-1H-pyrrole-3...)Show SMILES Cc1ccc(cc1)N1CC(=O)C(C(=O)Nc2ccc(OCCCCCCCn3cnnn3)cc2)C1=O Show InChI InChI=1S/C26H30N6O4/c1-19-7-11-21(12-8-19)32-17-23(33)24(26(32)35)25(34)28-20-9-13-22(14-10-20)36-16-6-4-2-3-5-15-31-18-27-29-30-31/h7-14,18,24H,2-6,15-17H2,1H3,(H,28,34) | PDB
MMDB
Reactome pathway
KEGG
UniProtKB/SwissProt
B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet
| CHEMBL
PC cid
PC sid
UniChem
Similars
| PubMed
| n/a | n/a | 890 | n/a | n/a | n/a | n/a | n/a | n/a |
Xenova Limited
Curated by ChEMBL
| Assay Description
Inhibitory activity against human plasminogen activator inhibitor-1(PAI-1) evaluated by chromogenic assay. |
Bioorg Med Chem Lett 12: 1063-6 (2002)
BindingDB Entry DOI: 10.7270/Q2W958HQ |
More data for this
Ligand-Target Pair | |
Plasminogen activator inhibitor 1
(Homo sapiens (Human)) | BDBM50111286
(8-{4-[(7-Cyano-4-hydroxy-2-oxo-1,2-dihydro-quinoli...)Show SMILES OC(=O)CCCCCCCOc1ccc(NC(=O)c2c(O)c3ccc(cc3[nH]c2=O)C#N)cc1 Show InChI InChI=1S/C25H25N3O6/c26-15-16-7-12-19-20(14-16)28-25(33)22(23(19)31)24(32)27-17-8-10-18(11-9-17)34-13-5-3-1-2-4-6-21(29)30/h7-12,14H,1-6,13H2,(H,27,32)(H,29,30)(H2,28,31,33) | PDB
MMDB
Reactome pathway
KEGG
UniProtKB/SwissProt
B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet
| CHEMBL
PC cid
PC sid
UniChem
Similars
| PubMed
| n/a | n/a | 900 | n/a | n/a | n/a | n/a | n/a | n/a |
Xenova Limited
Curated by ChEMBL
| Assay Description
Inhibitory activity against human plasminogen activator inhibitor-1(PAI-1) evaluated by chromogenic assay. |
Bioorg Med Chem Lett 12: 1063-6 (2002)
BindingDB Entry DOI: 10.7270/Q2W958HQ |
More data for this
Ligand-Target Pair | |
Plasminogen activator inhibitor 1
(Homo sapiens (Human)) | BDBM50111309
(8-{4-[(6-Benzo[b]thiophen-3-yl-4-hydroxy-2-oxo-1,2...)Show SMILES OC(=O)CCCCCCCOc1ccc(NC(=O)c2c(O)c3cc(ccc3[nH]c2=O)-c2csc3ccccc23)cc1 Show InChI InChI=1S/C32H30N2O6S/c35-28(36)10-4-2-1-3-7-17-40-22-14-12-21(13-15-22)33-31(38)29-30(37)24-18-20(11-16-26(24)34-32(29)39)25-19-41-27-9-6-5-8-23(25)27/h5-6,8-9,11-16,18-19H,1-4,7,10,17H2,(H,33,38)(H,35,36)(H2,34,37,39) | PDB
MMDB
Reactome pathway
KEGG
UniProtKB/SwissProt
B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet
| CHEMBL
PC cid
PC sid
UniChem
Similars
| PubMed
| n/a | n/a | 940 | n/a | n/a | n/a | n/a | n/a | n/a |
Xenova Limited
Curated by ChEMBL
| Assay Description
Inhibitory activity against human plasminogen activator inhibitor-1(PAI-1) evaluated by complex assay. |
Bioorg Med Chem Lett 12: 1063-6 (2002)
BindingDB Entry DOI: 10.7270/Q2W958HQ |
More data for this
Ligand-Target Pair | |
Plasminogen activator inhibitor 1
(Homo sapiens (Human)) | BDBM50111273
(6-Benzo[b]thiophen-2-yl-4-hydroxy-2-oxo-1,2-dihydr...)Show SMILES Oc1c(C(=O)Nc2ccc(OCCCCCCCn3cnnn3)cc2)c(=O)[nH]c2ccc(cc12)-c1cc2ccccc2s1 Show InChI InChI=1S/C32H30N6O4S/c39-30-25-18-22(28-19-21-8-4-5-9-27(21)43-28)10-15-26(25)35-32(41)29(30)31(40)34-23-11-13-24(14-12-23)42-17-7-3-1-2-6-16-38-20-33-36-37-38/h4-5,8-15,18-20H,1-3,6-7,16-17H2,(H,34,40)(H2,35,39,41) | PDB
MMDB
Reactome pathway
KEGG
UniProtKB/SwissProt
B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet
| CHEMBL
PC cid
PC sid
UniChem
Similars
| PubMed
| n/a | n/a | 1.01E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
Xenova Limited
Curated by ChEMBL
| Assay Description
Inhibitory activity against human plasminogen activator inhibitor-1(PAI-1) evaluated by complex assay. |
Bioorg Med Chem Lett 12: 1063-6 (2002)
BindingDB Entry DOI: 10.7270/Q2W958HQ |
More data for this
Ligand-Target Pair | |
Plasminogen activator inhibitor 1
(Homo sapiens (Human)) | BDBM50111284
(8-{4-[(4-Hydroxy-2-oxo-7-trifluoromethyl-1,2-dihyd...)Show SMILES OC(=O)CCCCCCCOc1ccc(NC(=O)c2c(O)c3ccc(cc3[nH]c2=O)C(F)(F)F)cc1 Show InChI InChI=1S/C25H25F3N2O6/c26-25(27,28)15-7-12-18-19(14-15)30-24(35)21(22(18)33)23(34)29-16-8-10-17(11-9-16)36-13-5-3-1-2-4-6-20(31)32/h7-12,14H,1-6,13H2,(H,29,34)(H,31,32)(H2,30,33,35) | PDB
MMDB
Reactome pathway
KEGG
UniProtKB/SwissProt
B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet
| CHEMBL
PC cid
PC sid
UniChem
Similars
| PubMed
| n/a | n/a | 1.03E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
Xenova Limited
Curated by ChEMBL
| Assay Description
Inhibitory activity against human plasminogen activator inhibitor-1(PAI-1) evaluated by chromogenic assay. |
Bioorg Med Chem Lett 12: 1063-6 (2002)
BindingDB Entry DOI: 10.7270/Q2W958HQ |
More data for this
Ligand-Target Pair | |
Delta-type opioid receptor/Kappa-type opioid receptor/Mu-type opioid receptor/Sigma non-opioid intracellular receptor 1
(Rattus norvegicus (rat)-RAT) | BDBM50223494
(CHEMBL1159833)Show SMILES CCC1C2Cc3ccc(O)cc3C1(CC)CCN2C(=O)C(N)CC(C)C |TLB:10:11:2:17.16.15| Show InChI InChI=1S/C22H34N2O2/c1-5-17-20-12-15-7-8-16(25)13-18(15)22(17,6-2)9-10-24(20)21(26)19(23)11-14(3)4/h7-8,13-14,17,19-20,25H,5-6,9-12,23H2,1-4H3 | PDB
MMDB
Reactome pathway
KEGG
UniProtKB/SwissProt
B.MOAD
DrugBank
GoogleScholar
AffyNet
| CHEMBL
PC cid
PC sid
UniChem
Similars
| PubMed
| n/a | n/a | 1.50E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
TBA
Curated by ChEMBL
| Assay Description
Compound was tested for its ability to displace [3H]naloxone from Opioid receptors in absence of NaCl |
J Med Chem 24: 1297-9 (1981)
BindingDB Entry DOI: 10.7270/Q20C4XZN |
More data for this
Ligand-Target Pair | |
Delta-type opioid receptor/Kappa-type opioid receptor/Mu-type opioid receptor/Sigma non-opioid intracellular receptor 1
(Rattus norvegicus (rat)-RAT) | BDBM50223495
(CHEMBL25778)Show SMILES Cl.CCC1C2Cc3ccc(O)cc3C1(CC)CCN2C(=O)C(N)Cc1ccccc1 |TLB:11:12:3:18.17.16| Show InChI InChI=1S/C25H32N2O2.ClH/c1-3-20-23-15-18-10-11-19(28)16-21(18)25(20,4-2)12-13-27(23)24(29)22(26)14-17-8-6-5-7-9-17;/h5-11,16,20,22-23,28H,3-4,12-15,26H2,1-2H3;1H | PDB
MMDB
Reactome pathway
KEGG
UniProtKB/SwissProt
B.MOAD
DrugBank
GoogleScholar
AffyNet
| CHEMBL
PC cid
PC sid
UniChem
Similars
| PubMed
| n/a | n/a | 1.54E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
TBA
Curated by ChEMBL
| Assay Description
Compound was tested for its ability to displace [3H]naloxone from Opioid receptors in absence of NaCl |
J Med Chem 24: 1297-9 (1981)
BindingDB Entry DOI: 10.7270/Q20C4XZN |
More data for this
Ligand-Target Pair | |
Plasminogen activator inhibitor 1
(Homo sapiens (Human)) | BDBM50111299
(8-{4-[(4-Hydroxy-6,7-dimethoxy-2-oxo-1,2-dihydro-q...)Show SMILES COc1cc2[nH]c(=O)c(C(=O)Nc3ccc(OCCCCCCCC(O)=O)cc3)c(O)c2cc1OC Show InChI InChI=1S/C26H30N2O8/c1-34-20-14-18-19(15-21(20)35-2)28-26(33)23(24(18)31)25(32)27-16-9-11-17(12-10-16)36-13-7-5-3-4-6-8-22(29)30/h9-12,14-15H,3-8,13H2,1-2H3,(H,27,32)(H,29,30)(H2,28,31,33) | PDB
MMDB
Reactome pathway
KEGG
UniProtKB/SwissProt
B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet
| CHEMBL
PC cid
PC sid
UniChem
Similars
| PubMed
| n/a | n/a | 1.65E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
Xenova Limited
Curated by ChEMBL
| Assay Description
Inhibitory activity against human plasminogen activator inhibitor-1(PAI-1) evaluated by chromogenic assay. |
Bioorg Med Chem Lett 12: 1063-6 (2002)
BindingDB Entry DOI: 10.7270/Q2W958HQ |
More data for this
Ligand-Target Pair | |
Plasminogen activator inhibitor 1
(Homo sapiens (Human)) | BDBM50111319
(8-{4-[(4-Hydroxy-2-oxo-6-pentyl-1,2-dihydro-quinol...)Show SMILES CCCCCc1ccc2[nH]c(=O)c(C(=O)Nc3ccc(OCCCCCCCC(O)=O)cc3)c(O)c2c1 Show InChI InChI=1S/C29H36N2O6/c1-2-3-7-10-20-12-17-24-23(19-20)27(34)26(29(36)31-24)28(35)30-21-13-15-22(16-14-21)37-18-9-6-4-5-8-11-25(32)33/h12-17,19H,2-11,18H2,1H3,(H,30,35)(H,32,33)(H2,31,34,36) | PDB
MMDB
Reactome pathway
KEGG
UniProtKB/SwissProt
B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet
| CHEMBL
PC cid
PC sid
UniChem
Similars
| PubMed
| n/a | n/a | 1.80E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
Xenova Limited
Curated by ChEMBL
| Assay Description
Inhibitory activity against human plasminogen activator inhibitor-1(PAI-1) evaluated by chromogenic assay. |
Bioorg Med Chem Lett 12: 1063-6 (2002)
BindingDB Entry DOI: 10.7270/Q2W958HQ |
More data for this
Ligand-Target Pair | |
Plasminogen activator inhibitor 1
(Homo sapiens (Human)) | BDBM50111306
(8-{4-[(4-Hydroxy-2-oxo-1,2-dihydro-quinoline-3-car...)Show SMILES OC(=O)CCCCCCCOc1ccc(NC(=O)c2c(O)c3ccccc3[nH]c2=O)cc1 Show InChI InChI=1S/C24H26N2O6/c27-20(28)10-4-2-1-3-7-15-32-17-13-11-16(12-14-17)25-23(30)21-22(29)18-8-5-6-9-19(18)26-24(21)31/h5-6,8-9,11-14H,1-4,7,10,15H2,(H,25,30)(H,27,28)(H2,26,29,31) | PDB
MMDB
Reactome pathway
KEGG
UniProtKB/SwissProt
B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet
| CHEMBL
PC cid
PC sid
UniChem
Similars
| PubMed
| n/a | n/a | 1.85E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
Xenova Limited
Curated by ChEMBL
| Assay Description
Inhibitory activity against human plasminogen activator inhibitor-1(PAI-1) evaluated by chromogenic assay. |
Bioorg Med Chem Lett 12: 1063-6 (2002)
BindingDB Entry DOI: 10.7270/Q2W958HQ |
More data for this
Ligand-Target Pair | |
Plasminogen activator inhibitor 1
(Homo sapiens (Human)) | BDBM50111313
(8-{4-[(6-Chloro-4-hydroxy-2-oxo-1,2-dihydro-quinol...)Show SMILES OC(=O)CCCCCCCOc1ccc(NC(=O)c2c(O)c3cc(Cl)ccc3[nH]c2=O)cc1 Show InChI InChI=1S/C24H25ClN2O6/c25-15-7-12-19-18(14-15)22(30)21(24(32)27-19)23(31)26-16-8-10-17(11-9-16)33-13-5-3-1-2-4-6-20(28)29/h7-12,14H,1-6,13H2,(H,26,31)(H,28,29)(H2,27,30,32) | PDB
MMDB
Reactome pathway
KEGG
UniProtKB/SwissProt
B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet
| CHEMBL
PC cid
PC sid
UniChem
Similars
| PubMed
| n/a | n/a | 1.95E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
Xenova Limited
Curated by ChEMBL
| Assay Description
Inhibitory activity against human plasminogen activator inhibitor-1(PAI-1) evaluated by chromogenic assay. |
Bioorg Med Chem Lett 12: 1063-6 (2002)
BindingDB Entry DOI: 10.7270/Q2W958HQ |
More data for this
Ligand-Target Pair | |
Plasminogen activator inhibitor 1
(Homo sapiens (Human)) | BDBM50111285
(8-(4-(4-hydroxy-2-oxo-1-p-tolyl-2,5-dihydro-1H-pyr...)Show SMILES Cc1ccc(cc1)N1CC(=O)C(C(=O)Nc2ccc(OCCCCCCCC(O)=O)cc2)C1=O Show InChI InChI=1S/C26H30N2O6/c1-18-8-12-20(13-9-18)28-17-22(29)24(26(28)33)25(32)27-19-10-14-21(15-11-19)34-16-6-4-2-3-5-7-23(30)31/h8-15,24H,2-7,16-17H2,1H3,(H,27,32)(H,30,31) | PDB
MMDB
Reactome pathway
KEGG
UniProtKB/SwissProt
B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet
| CHEMBL
PC cid
PC sid
UniChem
Similars
| PubMed
| n/a | n/a | 1.95E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
Xenova Limited
Curated by ChEMBL
| Assay Description
Inhibitory activity against human plasminogen activator inhibitor-1(PAI-1) evaluated by chromogenic assay. |
Bioorg Med Chem Lett 12: 1063-6 (2002)
BindingDB Entry DOI: 10.7270/Q2W958HQ |
More data for this
Ligand-Target Pair | |
Plasminogen activator inhibitor 1
(Homo sapiens (Human)) | BDBM50111288
(8-(4-{[1-(4-Bromo-phenyl)-4-hydroxy-2-oxo-2,5-dihy...)Show SMILES OC(=O)CCCCCCCOc1ccc(NC(=O)C2C(=O)CN(C2=O)c2ccc(Br)cc2)cc1 Show InChI InChI=1S/C25H27BrN2O6/c26-17-7-11-19(12-8-17)28-16-21(29)23(25(28)33)24(32)27-18-9-13-20(14-10-18)34-15-5-3-1-2-4-6-22(30)31/h7-14,23H,1-6,15-16H2,(H,27,32)(H,30,31) | PDB
MMDB
Reactome pathway
KEGG
UniProtKB/SwissProt
B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet
| CHEMBL
PC cid
PC sid
UniChem
Similars
| PubMed
| n/a | n/a | 1.99E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
Xenova Limited
Curated by ChEMBL
| Assay Description
Inhibitory activity against human plasminogen activator inhibitor-1(PAI-1) evaluated by chromogenic assay. |
Bioorg Med Chem Lett 12: 1063-6 (2002)
BindingDB Entry DOI: 10.7270/Q2W958HQ |
More data for this
Ligand-Target Pair | |
Plasminogen activator inhibitor 1
(Homo sapiens (Human)) | BDBM50111295
(8-(4-{[6-(4-Chloro-phenyl)-4-hydroxy-2-oxo-1,2-dih...)Show SMILES OC(=O)CCCCCCCOc1ccc(NC(=O)c2c(O)c3cc(ccc3[nH]c2=O)-c2ccc(Cl)cc2)cc1 Show InChI InChI=1S/C30H29ClN2O6/c31-21-10-7-19(8-11-21)20-9-16-25-24(18-20)28(36)27(30(38)33-25)29(37)32-22-12-14-23(15-13-22)39-17-5-3-1-2-4-6-26(34)35/h7-16,18H,1-6,17H2,(H,32,37)(H,34,35)(H2,33,36,38) | PDB
MMDB
Reactome pathway
KEGG
UniProtKB/SwissProt
B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet
| CHEMBL
PC cid
PC sid
UniChem
Similars
| PubMed
| n/a | n/a | 2.00E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
Xenova Limited
Curated by ChEMBL
| Assay Description
Inhibitory activity against human plasminogen activator inhibitor-1(PAI-1) evaluated by chromogenic assay. |
Bioorg Med Chem Lett 12: 1063-6 (2002)
BindingDB Entry DOI: 10.7270/Q2W958HQ |
More data for this
Ligand-Target Pair | |
Plasminogen activator inhibitor 1
(Homo sapiens (Human)) | BDBM50111308
(8-{4-[(4-Hydroxy-6-iodo-2-oxo-1,2-dihydro-quinolin...)Show SMILES OC(=O)CCCCCCCOc1ccc(NC(=O)c2c(O)c3cc(I)ccc3[nH]c2=O)cc1 Show InChI InChI=1S/C24H25IN2O6/c25-15-7-12-19-18(14-15)22(30)21(24(32)27-19)23(31)26-16-8-10-17(11-9-16)33-13-5-3-1-2-4-6-20(28)29/h7-12,14H,1-6,13H2,(H,26,31)(H,28,29)(H2,27,30,32) | PDB
MMDB
Reactome pathway
KEGG
UniProtKB/SwissProt
B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet
| CHEMBL
PC cid
PC sid
UniChem
Similars
| PubMed
| n/a | n/a | 2.20E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
Xenova Limited
Curated by ChEMBL
| Assay Description
Inhibitory activity against human plasminogen activator inhibitor-1(PAI-1) evaluated by chromogenic assay. |
Bioorg Med Chem Lett 12: 1063-6 (2002)
BindingDB Entry DOI: 10.7270/Q2W958HQ |
More data for this
Ligand-Target Pair | |
Plasminogen activator inhibitor 1
(Homo sapiens (Human)) | BDBM50111296
(8-(4-{[4-Hydroxy-1-(4-isopropyl-phenyl)-2-oxo-2,5-...)Show SMILES CC(C)c1ccc(cc1)N1CC(=O)C(C(=O)Nc2ccc(OCCCCCCCC(O)=O)cc2)C1=O Show InChI InChI=1S/C28H34N2O6/c1-19(2)20-9-13-22(14-10-20)30-18-24(31)26(28(30)35)27(34)29-21-11-15-23(16-12-21)36-17-7-5-3-4-6-8-25(32)33/h9-16,19,26H,3-8,17-18H2,1-2H3,(H,29,34)(H,32,33) | PDB
MMDB
Reactome pathway
KEGG
UniProtKB/SwissProt
B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet
| CHEMBL
PC cid
PC sid
UniChem
Similars
| PubMed
| n/a | n/a | 2.35E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
Xenova Limited
Curated by ChEMBL
| Assay Description
Inhibitory activity against human plasminogen activator inhibitor-1(PAI-1) evaluated by chromogenic assay. |
Bioorg Med Chem Lett 12: 1063-6 (2002)
BindingDB Entry DOI: 10.7270/Q2W958HQ |
More data for this
Ligand-Target Pair | |
Plasminogen activator inhibitor 1
(Homo sapiens (Human)) | BDBM50111314
(8-{4-[(6,7-Difluoro-4-hydroxy-2-oxo-1,2-dihydro-qu...)Show SMILES OC(=O)CCCCCCCOc1ccc(NC(=O)c2c(O)c3cc(F)c(F)cc3[nH]c2=O)cc1 Show InChI InChI=1S/C24H24F2N2O6/c25-17-12-16-19(13-18(17)26)28-24(33)21(22(16)31)23(32)27-14-7-9-15(10-8-14)34-11-5-3-1-2-4-6-20(29)30/h7-10,12-13H,1-6,11H2,(H,27,32)(H,29,30)(H2,28,31,33) | PDB
MMDB
Reactome pathway
KEGG
UniProtKB/SwissProt
B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet
| CHEMBL
PC cid
PC sid
UniChem
Similars
| PubMed
| n/a | n/a | 2.35E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
Xenova Limited
Curated by ChEMBL
| Assay Description
Inhibitory activity against human plasminogen activator inhibitor-1(PAI-1) evaluated by chromogenic assay. |
Bioorg Med Chem Lett 12: 1063-6 (2002)
BindingDB Entry DOI: 10.7270/Q2W958HQ |
More data for this
Ligand-Target Pair | |
Plasminogen activator inhibitor 1
(Homo sapiens (Human)) | BDBM50111303
(8-{4-[(5-Chloro-4-hydroxy-2-oxo-1,2-dihydro-quinol...)Show SMILES OC(=O)CCCCCCCOc1ccc(NC(=O)c2c(O)c3c(Cl)cccc3[nH]c2=O)cc1 Show InChI InChI=1S/C24H25ClN2O6/c25-17-7-6-8-18-20(17)22(30)21(24(32)27-18)23(31)26-15-10-12-16(13-11-15)33-14-5-3-1-2-4-9-19(28)29/h6-8,10-13H,1-5,9,14H2,(H,26,31)(H,28,29)(H2,27,30,32) | PDB
MMDB
Reactome pathway
KEGG
UniProtKB/SwissProt
B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet
| CHEMBL
PC cid
PC sid
UniChem
Similars
| PubMed
| n/a | n/a | 3.00E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
Xenova Limited
Curated by ChEMBL
| Assay Description
Inhibitory activity against human plasminogen activator inhibitor-1(PAI-1) evaluated by chromogenic assay. |
Bioorg Med Chem Lett 12: 1063-6 (2002)
BindingDB Entry DOI: 10.7270/Q2W958HQ |
More data for this
Ligand-Target Pair | |
Delta-type opioid receptor/Kappa-type opioid receptor/Mu-type opioid receptor/Sigma non-opioid intracellular receptor 1
(Rattus norvegicus (rat)-RAT) | BDBM50223495
(CHEMBL25778)Show SMILES Cl.CCC1C2Cc3ccc(O)cc3C1(CC)CCN2C(=O)C(N)Cc1ccccc1 |TLB:11:12:3:18.17.16| Show InChI InChI=1S/C25H32N2O2.ClH/c1-3-20-23-15-18-10-11-19(28)16-21(18)25(20,4-2)12-13-27(23)24(29)22(26)14-17-8-6-5-7-9-17;/h5-11,16,20,22-23,28H,3-4,12-15,26H2,1-2H3;1H | PDB
MMDB
Reactome pathway
KEGG
UniProtKB/SwissProt
B.MOAD
DrugBank
GoogleScholar
AffyNet
| CHEMBL
PC cid
PC sid
UniChem
Similars
| PubMed
| n/a | n/a | 3.35E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
TBA
Curated by ChEMBL
| Assay Description
Compound was tested for its ability to displace [3H]naloxone from Opioid receptors in presence of NaCl (100 mM) |
J Med Chem 24: 1297-9 (1981)
BindingDB Entry DOI: 10.7270/Q20C4XZN |
More data for this
Ligand-Target Pair | |
Plasminogen activator inhibitor 1
(Homo sapiens (Human)) | BDBM50111277
(8-{4-[(4-Hydroxy-6-nitro-2-oxo-1,2-dihydro-quinoli...)Show SMILES OC(=O)CCCCCCCOc1ccc(NC(=O)c2c(O)c3cc(ccc3[nH]c2=O)[N+]([O-])=O)cc1 Show InChI InChI=1S/C24H25N3O8/c28-20(29)6-4-2-1-3-5-13-35-17-10-7-15(8-11-17)25-23(31)21-22(30)18-14-16(27(33)34)9-12-19(18)26-24(21)32/h7-12,14H,1-6,13H2,(H,25,31)(H,28,29)(H2,26,30,32) | PDB
MMDB
Reactome pathway
KEGG
UniProtKB/SwissProt
B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet
| CHEMBL
PC cid
PC sid
UniChem
Similars
| PubMed
| n/a | n/a | 3.60E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
Xenova Limited
Curated by ChEMBL
| Assay Description
Inhibitory activity against human plasminogen activator inhibitor-1(PAI-1) evaluated by chromogenic assay. |
Bioorg Med Chem Lett 12: 1063-6 (2002)
BindingDB Entry DOI: 10.7270/Q2W958HQ |
More data for this
Ligand-Target Pair | |
Plasminogen activator inhibitor 1
(Homo sapiens (Human)) | BDBM50111283
(8-(4-{[4-Hydroxy-1-(4-methoxy-phenyl)-2-oxo-2,5-di...)Show SMILES COc1ccc(cc1)N1CC(=O)C(C(=O)Nc2ccc(OCCCCCCCC(O)=O)cc2)C1=O Show InChI InChI=1S/C26H30N2O7/c1-34-20-14-10-19(11-15-20)28-17-22(29)24(26(28)33)25(32)27-18-8-12-21(13-9-18)35-16-6-4-2-3-5-7-23(30)31/h8-15,24H,2-7,16-17H2,1H3,(H,27,32)(H,30,31) | PDB
MMDB
Reactome pathway
KEGG
UniProtKB/SwissProt
B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet
| CHEMBL
PC cid
PC sid
UniChem
Similars
| PubMed
| n/a | n/a | 3.66E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
Xenova Limited
Curated by ChEMBL
| Assay Description
Inhibitory activity against human plasminogen activator inhibitor-1(PAI-1) evaluated by chromogenic assay. |
Bioorg Med Chem Lett 12: 1063-6 (2002)
BindingDB Entry DOI: 10.7270/Q2W958HQ |
More data for this
Ligand-Target Pair | |
Plasminogen activator inhibitor 1
(Homo sapiens (Human)) | BDBM50111304
(8-{4-[(4-Hydroxy-1-naphthalen-2-yl-2-oxo-2,5-dihyd...)Show SMILES OC(=O)CCCCCCCOc1ccc(NC(=O)C2C(=O)CN(C2=O)c2ccc3ccccc3c2)cc1 Show InChI InChI=1S/C29H30N2O6/c32-25-19-31(23-14-11-20-8-5-6-9-21(20)18-23)29(36)27(25)28(35)30-22-12-15-24(16-13-22)37-17-7-3-1-2-4-10-26(33)34/h5-6,8-9,11-16,18,27H,1-4,7,10,17,19H2,(H,30,35)(H,33,34) | PDB
MMDB
Reactome pathway
KEGG
UniProtKB/SwissProt
B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet
| CHEMBL
PC cid
PC sid
UniChem
Similars
| PubMed
| n/a | n/a | 4.00E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
Xenova Limited
Curated by ChEMBL
| Assay Description
Inhibitory activity against human plasminogen activator inhibitor-1(PAI-1) evaluated by chromogenic assay. |
Bioorg Med Chem Lett 12: 1063-6 (2002)
BindingDB Entry DOI: 10.7270/Q2W958HQ |
More data for this
Ligand-Target Pair | |
Plasminogen activator inhibitor 1
(Homo sapiens (Human)) | BDBM50111300
(8-{4-[(5-Amino-4-hydroxy-2-oxo-1,2-dihydro-quinoli...)Show SMILES Nc1cccc2[nH]c(=O)c(C(=O)Nc3ccc(OCCCCCCCC(O)=O)cc3)c(O)c12 Show InChI InChI=1S/C24H27N3O6/c25-17-7-6-8-18-20(17)22(30)21(24(32)27-18)23(31)26-15-10-12-16(13-11-15)33-14-5-3-1-2-4-9-19(28)29/h6-8,10-13H,1-5,9,14,25H2,(H,26,31)(H,28,29)(H2,27,30,32) | PDB
MMDB
Reactome pathway
KEGG
UniProtKB/SwissProt
B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet
| CHEMBL
PC cid
PC sid
UniChem
Similars
| PubMed
| n/a | n/a | 4.25E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
Xenova Limited
Curated by ChEMBL
| Assay Description
Inhibitory activity against human plasminogen activator inhibitor-1(PAI-1) evaluated by chromogenic assay. |
Bioorg Med Chem Lett 12: 1063-6 (2002)
BindingDB Entry DOI: 10.7270/Q2W958HQ |
More data for this
Ligand-Target Pair | |
Plasminogen activator inhibitor 1
(Homo sapiens (Human)) | BDBM50111312
(8-(4-{[4-Hydroxy-1-(4-nitro-phenyl)-2-oxo-2,5-dihy...)Show SMILES OC(=O)CCCCCCCOc1ccc(NC(=O)C2C(=O)CN(C2=O)c2ccc(cc2)[N+]([O-])=O)cc1 Show InChI InChI=1S/C25H27N3O8/c29-21-16-27(18-9-11-19(12-10-18)28(34)35)25(33)23(21)24(32)26-17-7-13-20(14-8-17)36-15-5-3-1-2-4-6-22(30)31/h7-14,23H,1-6,15-16H2,(H,26,32)(H,30,31) | PDB
MMDB
Reactome pathway
KEGG
UniProtKB/SwissProt
B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet
| CHEMBL
PC cid
PC sid
UniChem
Similars
| PubMed
| n/a | n/a | 4.25E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
Xenova Limited
Curated by ChEMBL
| Assay Description
Inhibitory activity against human plasminogen activator inhibitor-1(PAI-1) evaluated by chromogenic assay. |
Bioorg Med Chem Lett 12: 1063-6 (2002)
BindingDB Entry DOI: 10.7270/Q2W958HQ |
More data for this
Ligand-Target Pair | |
Plasminogen activator inhibitor 1
(Homo sapiens (Human)) | BDBM50111289
(8-{4-[(6-Fluoro-4-hydroxy-2-oxo-1,2-dihydro-quinol...)Show SMILES OC(=O)CCCCCCCOc1ccc(NC(=O)c2c(O)c3cc(F)ccc3[nH]c2=O)cc1 Show InChI InChI=1S/C24H25FN2O6/c25-15-7-12-19-18(14-15)22(30)21(24(32)27-19)23(31)26-16-8-10-17(11-9-16)33-13-5-3-1-2-4-6-20(28)29/h7-12,14H,1-6,13H2,(H,26,31)(H,28,29)(H2,27,30,32) | PDB
MMDB
Reactome pathway
KEGG
UniProtKB/SwissProt
B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet
| CHEMBL
PC cid
PC sid
UniChem
Similars
| PubMed
| n/a | n/a | 4.90E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
Xenova Limited
Curated by ChEMBL
| Assay Description
Inhibitory activity against human plasminogen activator inhibitor-1(PAI-1) evaluated by chromogenic assay. |
Bioorg Med Chem Lett 12: 1063-6 (2002)
BindingDB Entry DOI: 10.7270/Q2W958HQ |
More data for this
Ligand-Target Pair | |
Plasminogen activator inhibitor 1
(Homo sapiens (Human)) | BDBM50111274
(8-(4-(1-(4-chlorophenyl)-4-hydroxy-2-oxo-2,5-dihyd...)Show SMILES OC(=O)CCCCCCCOc1ccc(NC(=O)C2C(=O)CN(C2=O)c2ccc(Cl)cc2)cc1 Show InChI InChI=1S/C25H27ClN2O6/c26-17-7-11-19(12-8-17)28-16-21(29)23(25(28)33)24(32)27-18-9-13-20(14-10-18)34-15-5-3-1-2-4-6-22(30)31/h7-14,23H,1-6,15-16H2,(H,27,32)(H,30,31) | PDB
MMDB
Reactome pathway
KEGG
UniProtKB/SwissProt
B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet
| CHEMBL
PC cid
PC sid
UniChem
Similars
| PubMed
| n/a | n/a | 5.00E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
Xenova Limited
Curated by ChEMBL
| Assay Description
Inhibitory activity against human plasminogen activator inhibitor-1(PAI-1) evaluated by chromogenic assay. |
Bioorg Med Chem Lett 12: 1063-6 (2002)
BindingDB Entry DOI: 10.7270/Q2W958HQ |
More data for this
Ligand-Target Pair | |
Delta-type opioid receptor/Kappa-type opioid receptor/Mu-type opioid receptor/Sigma non-opioid intracellular receptor 1
(Rattus norvegicus (rat)-RAT) | BDBM50223496
(CHEMBL282347)Show SMILES Cl.CCC1C2Cc3ccc(O)cc3C1(CC)CCN2C(=O)C(N)CCSC |TLB:11:12:3:18.17.16| Show InChI InChI=1S/C21H32N2O2S.ClH/c1-4-16-19-12-14-6-7-15(24)13-17(14)21(16,5-2)9-10-23(19)20(25)18(22)8-11-26-3;/h6-7,13,16,18-19,24H,4-5,8-12,22H2,1-3H3;1H | PDB
MMDB
Reactome pathway
KEGG
UniProtKB/SwissProt
B.MOAD
DrugBank
GoogleScholar
AffyNet
| CHEMBL
PC cid
PC sid
UniChem
Similars
| PubMed
| n/a | n/a | 5.59E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
TBA
Curated by ChEMBL
| Assay Description
Compound was tested for its ability to displace [3H]naloxone from Opioid receptors in presence of NaCl (100 mM) |
J Med Chem 24: 1297-9 (1981)
BindingDB Entry DOI: 10.7270/Q20C4XZN |
More data for this
Ligand-Target Pair | |
Delta-type opioid receptor/Kappa-type opioid receptor/Mu-type opioid receptor/Sigma non-opioid intracellular receptor 1
(Rattus norvegicus (rat)-RAT) | BDBM50223494
(CHEMBL1159833)Show SMILES CCC1C2Cc3ccc(O)cc3C1(CC)CCN2C(=O)C(N)CC(C)C |TLB:10:11:2:17.16.15| Show InChI InChI=1S/C22H34N2O2/c1-5-17-20-12-15-7-8-16(25)13-18(15)22(17,6-2)9-10-24(20)21(26)19(23)11-14(3)4/h7-8,13-14,17,19-20,25H,5-6,9-12,23H2,1-4H3 | PDB
MMDB
Reactome pathway
KEGG
UniProtKB/SwissProt
B.MOAD
DrugBank
GoogleScholar
AffyNet
| CHEMBL
PC cid
PC sid
UniChem
Similars
| PubMed
| n/a | n/a | 6.38E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
TBA
Curated by ChEMBL
| Assay Description
Compound was tested for its ability to displace [3H]naloxone from Opioid receptors in presence of NaCl (100 mM) |
J Med Chem 24: 1297-9 (1981)
BindingDB Entry DOI: 10.7270/Q20C4XZN |
More data for this
Ligand-Target Pair | |
Plasminogen activator inhibitor 1
(Homo sapiens (Human)) | BDBM50111318
(8-{4-[(4-Hydroxy-5-iodo-2-oxo-1,2-dihydro-quinolin...)Show SMILES OC(=O)CCCCCCCOc1ccc(NC(=O)c2c(O)c3c(I)cccc3[nH]c2=O)cc1 Show InChI InChI=1S/C24H25IN2O6/c25-17-7-6-8-18-20(17)22(30)21(24(32)27-18)23(31)26-15-10-12-16(13-11-15)33-14-5-3-1-2-4-9-19(28)29/h6-8,10-13H,1-5,9,14H2,(H,26,31)(H,28,29)(H2,27,30,32) | PDB
MMDB
Reactome pathway
KEGG
UniProtKB/SwissProt
B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet
| CHEMBL
PC cid
PC sid
UniChem
Similars
| PubMed
| n/a | n/a | 7.00E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
Xenova Limited
Curated by ChEMBL
| Assay Description
Inhibitory activity against human plasminogen activator inhibitor-1(PAI-1) evaluated by chromogenic assay. |
Bioorg Med Chem Lett 12: 1063-6 (2002)
BindingDB Entry DOI: 10.7270/Q2W958HQ |
More data for this
Ligand-Target Pair | |
Plasminogen activator inhibitor 1
(Homo sapiens (Human)) | BDBM50111305
(8-{4-[(4-Hydroxy-5-nitro-2-oxo-1,2-dihydro-quinoli...)Show SMILES OC(=O)CCCCCCCOc1ccc(NC(=O)c2c(O)c3c(cccc3[nH]c2=O)[N+]([O-])=O)cc1 Show InChI InChI=1S/C24H25N3O8/c28-19(29)9-4-2-1-3-5-14-35-16-12-10-15(11-13-16)25-23(31)21-22(30)20-17(26-24(21)32)7-6-8-18(20)27(33)34/h6-8,10-13H,1-5,9,14H2,(H,25,31)(H,28,29)(H2,26,30,32) | PDB
MMDB
Reactome pathway
KEGG
UniProtKB/SwissProt
B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet
| CHEMBL
PC cid
PC sid
UniChem
Similars
| PubMed
| n/a | n/a | 7.90E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
Xenova Limited
Curated by ChEMBL
| Assay Description
Inhibitory activity against human plasminogen activator inhibitor-1(PAI-1) evaluated by chromogenic assay. |
Bioorg Med Chem Lett 12: 1063-6 (2002)
BindingDB Entry DOI: 10.7270/Q2W958HQ |
More data for this
Ligand-Target Pair | |
Delta-type opioid receptor/Kappa-type opioid receptor/Mu-type opioid receptor/Sigma non-opioid intracellular receptor 1
(Rattus norvegicus (rat)-RAT) | BDBM50223498
(CHEMBL286206)Show SMILES Cl.CCC1C2Cc3ccc(O)cc3C1(CC)CCN2C(=O)CN |TLB:11:12:3:18.17.16| Show InChI InChI=1S/C18H26N2O2.ClH/c1-3-14-16-9-12-5-6-13(21)10-15(12)18(14,4-2)7-8-20(16)17(22)11-19;/h5-6,10,14,16,21H,3-4,7-9,11,19H2,1-2H3;1H | PDB
MMDB
Reactome pathway
KEGG
UniProtKB/SwissProt
B.MOAD
DrugBank
GoogleScholar
AffyNet
| CHEMBL
PC cid
PC sid
UniChem
Similars
| PubMed
| n/a | n/a | 8.18E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
TBA
Curated by ChEMBL
| Assay Description
Compound was tested for its ability to displace [3H]naloxone from Opioid receptors in presence of NaCl (100 mM) |
J Med Chem 24: 1297-9 (1981)
BindingDB Entry DOI: 10.7270/Q20C4XZN |
More data for this
Ligand-Target Pair | |
Search and Browse
